Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2020 Dividend
May 20 2020 - 4:30PM
Business Wire
Zoetis Inc. (NYSE:ZTS) today announced the results of
shareholder voting at its 2020 Annual Meeting of Shareholders and
provided details on its third quarter 2020 dividend.
Virtual Annual Meeting of Shareholders
Zoetis held a virtual annual meeting today, with Chairman
Michael B. McCallister presiding over the business portion of the
meeting and shareholder voting. Chief Executive Officer Kristin
Peck discussed the company’s strong performance in 2019, the
essential role that Zoetis plays in sustaining and protecting
animal and human life during the COVID-19 pandemic, and its top
priorities for continued growth and market leadership in the global
animal health industry.
As part of her remarks about the company, Peck said, “In 2019,
we achieved operational revenue growth of 10% and grew adjusted net
income 14% operationally, while continuing to create value for our
investors.”
“As we started 2020, none of us could have predicted the
circumstances we would face as a company and a society with the
outbreak of COVID-19. The past few months have been unlike any we
have ever experienced in business, or that any of us could have
imagined for our families, friends and communities,” continued
Peck. “It has been an experience that has tested us, galvanized our
team and brought out the best in our colleagues around the world. I
could not be prouder.”
“I laid out five priorities for Zoetis: Driving Innovative
Growth; Enhancing Customer Experience; Leading in Digital and Data
Analytics; Cultivating a High-Performing Organization; and
Championing a Healthier, More Sustainable Future. While timing and
tactics may be adjusted in light of the COVID-19 pandemic, they are
as relevant today as they were then. I look forward to sharing
updates in the future as we make progress along these priorities
and emerge from this pandemic stronger, more innovative, and more
agile than ever,” said Peck.
Shareholder Voting Results
The results of shareholder voting from the meeting were as
follows:
- Gregory Norden, Louise Parent, Kristin Peck and Robert Scully
have been elected as directors for three-year terms.
- Shareholders approved, on an advisory basis, the compensation
of the company’s named executive officers.
- Shareholders approved, on an advisory basis, the frequency of
future advisory votes on the Company’s executive compensation.
- Shareholders ratified and approved the selection of KPMG LLP as
the company’s independent registered public accounting firm for
fiscal year 2020.
A full replay of the meeting will be made available at
http://investor.zoetis.com/events-presentations, along with the
presentation materials from the event.
Quarterly Dividend Declared
In separate proceedings today, the Zoetis Board of Directors
declared a third quarter 2020 dividend payable to holders of the
company’s common stock of $0.20 per share; the dividend is to be
paid on Tuesday, Sept. 1, 2020, to holders of record on Friday,
July 17, 2020.
About Zoetis
Zoetis is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more
than 65 years of experience in animal health, Zoetis discovers,
develops, manufactures and commercializes medicines, vaccines and
diagnostic products, which are complemented by biodevices, genetic
tests and precision livestock farming. Zoetis serves veterinarians,
livestock producers and people who raise and care for farm and
companion animals with sales of its products in more than 100
countries. In 2019, the company generated annual revenue of $6.3
billion with approximately 10,600 employees. For more information,
visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-looking Information:
This press release contains forward-looking statements, which
reflect the current views of Zoetis with respect to general
industry conditions and competition, general economic factors, the
impact of the recent global outbreak of novel coronavirus disease
(COVID-19), business plans or prospects, future operating or
financial performance, future guidance, future operating models,
expectations regarding products, future use of cash and dividend
payments, risks or expectations related to its indebtedness, and
other future events. These statements are not guarantees of future
performance or actions. Forward-looking statements are subject to
risks and uncertainties. If one or more of these risks or
uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ
materially from those contemplated by a forward-looking statement.
Forward-looking statements speak only as of the date on which they
are made. Zoetis expressly disclaims any obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. A further list and
description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2019, including in the sections thereof captioned
“Forward-Looking Statements and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on
Form 10-Q and in our Current Reports on Form 8-K. Such risks and
uncertainties may be amplified by the coronavirus (COVID-19)
pandemic and its impact on the global economy and our business.
These filings and subsequent filings are available online at
www.sec.gov, www.zoetis.com, or on request from Zoetis.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200520005837/en/
Media Contacts: Christina Lood
1-973-822-7249 (o) christina.lood@zoetis.com
Kristen Seely 1-973-443-2777 (o) kristen.seely@zoetis.com
Investor Contacts: Steve Frank
1-973-822-7141 (o) steve.frank@zoetis.com
Marissa Patel 1-973-443-2996 (o) marissa.patel@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Apr 2023 to Apr 2024